title: The role of dyslipidemia in diabetic retinopathy: a brighter focus?
authors.affiliation: Laboratory for Atherosclerosis and Metabolic Research and Division of Endocrinology, Diabetes and Metabolism, Department of Medicine, University of California Davis Medical Center, Sacramento, CA. Electronic address: ishwarlal.jialal@ucdmc.ucdavis.edu.
authors.forename: I
authors.initials: I
authors.lastname: Jialal
authors.affiliation: Laboratory for Atherosclerosis and Metabolic Research and Division of Endocrinology, Diabetes and Metabolism, Department of Medicine, University of California Davis Medical Center, Sacramento, CA.
authors.forename: U
authors.initials: U
authors.lastname: Rajamani
authors.affiliation: Veterance Affairs Medical Center, Sacramento, CA.
authors.forename: David
authors.initials: D
authors.lastname: Siegel
mesh_terms: D003430:Cross-Sectional Studies; D003920:Diabetes Mellitus / Q000188:drug therapy; D003930:Diabetic Retinopathy / Q000209:etiology* / Q000517:prevention & control; D050171:Dyslipidemias / Q000150:complications*; D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000627:therapeutic use; D015201:Meta-Analysis as Topic; D012307:Risk Factors
chemical_list: D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors